Over the past 15 months, the Singapore state investor committed nearly $4 billion in capital, including its stake in Manipal Healthcare Enterprises. It expects to deploy $9-10 billion within the next three years, the executives said.
Ahmedabad-based Nirma group and leading private equity firms have joined the race to acquire BSE-listed Glenmark Life Sciences.
The acquisition by chemicals-to-cement major Nirma, if successful, would be a major boost for the health-care segment of the group, on the lines of its successful entry into the cement sector following its purchase of Lafarge India s assets for about Rs 9,400 crore in July 2016.
It later followed up by buying Emami cement assets for Rs 5,500 crore in February 2020.